Browse by Creator

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping | Creators | Date
Number of items: 58.

Article

May, J. E., Pemberton, R., Hart, J. P., McLeod, J. D., Wilcock, G. and Doran, O. (2013) Use of whole blood for analysis of disease-associated biomarkers. Analytical Biochemistry, 437 (1). pp. 59-61. ISSN 0003-2697

Kehoe, P. G. and Wilcock, G. (2007) Is inhibition of the renin–angiotensin system a new treatment option for Alzheimer's disease. The Lancet Neurology, 6 (4). pp. 373-378. ISSN 1474-4422

Vellas, B., Sampaio, C., Andrieu, S. and Wilcock, G. (2007) Disease-modifying trials in Alzheimer's disease: A European task force consensus. The Lancet Neurology, 6 (1). pp. 56-62. ISSN 1474-4422

Tales, A., Brown, M., Snowden, R. and Wilcock, G. (2006) Alerting and orienting in Alzheimer's Disease. Neuropsychology, 20 (6). pp. 752-756. ISSN 0894-4105

Hughes, A., Culpan, D., Price, J., Palmer, L., Kehoe, P., Love, S., Matthews, S. and Wilcock, G. (2006) Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer s disease. Neuroscience letters, 408 (2). pp. 141-5. ISSN 0304-3940

Miners, J., Chalmers, K., Kehoe, P., Love, S., Helmond, Z. and Wilcock, G. (2006) Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. Journal of Neuropathology & Experimental Neurology, 65 (10). pp. 1012-1021. ISSN 0022-3069

Byrne-Davis, L., Bennett, P. and Wilcock, G. (2006) How are quality of life ratings made toward a model of quality of life in people with dementia. Quality of Life Research, 15 (5). pp. 855-865. ISSN 0962-9343

Shlomo, B., Dawbarn, D., Siew, L., Love, S., Allen, S. and Wilcock, G. (2006) Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiology of Aging, 27 (6). pp. 797-803. ISSN 0197-4580

Burns, A., McCaddon, A., Thomas, A., Ballard, C., Jacova, C., Richie, C., Wilkinson, D., Ford, G., Feldman, H., O'Brien, J., Warner, J., Orgogozo, J., Broich, K., Knapp, M., McKeith, M., Richardson, M., Purandare, N., Bullock, R., Jones, R., Auriacombe, S., Lennon, S., Lliffe, S. and Wilcock, G. (2006) Clinical practice with anti-dementia drugs: A consensus statement from British Association for Psychopharmacology. Journal of Psychopharmacology , 20 (6). pp. 732-755. ISSN 0269-8811

Wilcock, G. (2006) Dementia: Where has 2005 taken us? The Lancet Neurology, 5 (1). pp. 11-12. ISSN 1474-4422

Vreugdenhil, A., Razay, G. and Wilcock, G. (2006) Obesity, abdominal obesity and Alzheimer disease. Dementia Geriatric Cognitive Disorders, 22 (2). pp. 173-176.

Chalmers, K., Love, S. and Wilcock, G. (2005) Contributors to white matter damage in the frontal lobe in Alzheimer's disease. Neuropathology and applied neurobiology, 31 (6). pp. 623-631. ISSN 0305-1846

Baig, S., Wilcock, G. and Love, S. (2005) Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Acta Neuropathol, 110 (4). pp. 393-401. ISSN 0001-6322

Chalmers, K., Love, S., Williams, S. and Wilcock, G. (2005) Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathology and applied neurobiology, 31 (4). pp. 414-421. ISSN 0305-1846

Chalmers, K., Blomqvist, M.-L., Andreasen, N., Bogdanovic, N. and Wilcock, G. (2005) Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobilogy of Aging, 26 (6). pp. 795-802. ISSN 0197-4580

Tales, A., Haworth, R., Snowden, R. and Wilcock, G. (2005) Abnormal spatial and non-spatial cueing effects in mild cognitive impairment and Alzheimer's disease. Neurocase, 11 (1). pp. 85-92. ISSN 1355-4794

Tales, A., Haworth, J., Nelson, S. J., Snowden, R. and Wilcock, G. (2005) Abnormal visual search in mild cognitive impairment and Alzheimer's disease. Neurocase, 11 (1). pp. 80-84. ISSN 1355-4794

Combrinck, M., Wozniak, M., Itzhaki, R., Shipley, S. and Wilcock, G. (2004) Productive herpes simplex virus in brain of elderly normal subjects and Alzheimer's disease patients. Journal of Medical Virology, 75 (2). pp. 300-306. ISSN 0146-6615

Damaraju, C., Truyen, L., Pirtilla, T. and Wilcock, G. (2004) Long-term efficacy and safety of galantamine in patients with mild-to-moderate Alzheimer's disease multicenter trial. European Journal of Neurology, 11 (11). pp. 734-741. ISSN 1351-5101

Whitehead, A., Perdomo, C., Birks, J., Evans, J., Prat, R. and Wilcock, G. (2004) Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer s disease a meta-analysis of individual patient data from randomised controlled trials. International Journal of Geriatric Pyschiatry, 19 (7). pp. 624-33. ISSN 0885-6230

Haworth, J., Condefer, K. and Wilcock, G. (2004) Clinical utility of computed tomography in the assessment of dementia: A memory clinic study. International Journal of Geriatric Psychiatry, 19 (5). pp. 414-21. ISSN 0885-6230

Katzov, H., Gatz, M., Andreasen, N., Cairns, N., Kehoe, P. and Wilcock, G. (2004) Common variants of ACE contribute to variable age-at-onset of Alzheimer's disease. Human Genetics, 114 (5). pp. 478-483. ISSN 0340-6717

Katzov, H., Chalmers, K., Palmgren, J., Andreasen, N., Johansson, B., Cairns, N. J., Gatz, M., Wilcock, G., Love, S., Pedersen, N. L., Brookes, A. J., Blennow, K., Kehoe, P. G. and Prince, J. A. (2004) Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Human Mutation, 23 (4). pp. 358-367. ISSN 1098-1004

Birks, J. and Wilcock, G. (2004) Velnacrine for Alzheimer's disease. The Cochrane Database of Systematic Reviews, 2.

Evans, J. G., Wilcock, G. and Birks, J. (2004) Evidence-based pharmacotherapy of Alzheimer's disease. International Journal of Neuropsychopharmacology, 7 (3). pp. 351-369. ISSN 1461-1457

Dawbarn, D., Siew, L., Love, S., Allen, S. and Wilcock, G. (2004) Measurement of pre- and post-synaptic proteins in cerebral cortex effects of post-mortem delay. Journal of neuroscience methods, 139 (2). pp. 153-159. ISSN 0165-0270

Culpan, D., MacGowan, S., Ford, J., Nicoll, J., Griffin, W. S., Dewar, D., Cairns, N., Hughes, A., Kehoe, P. and Wilcock, G. (2003) Tumour necrosis factor-alpha gene polymorphisms and Alzheimer's disease. Neuroscience Letters, 350 (1). pp. 61-65. ISSN 0304-3940

Radenahmad, N., Neal, J., Wilcock, G. and Pearson, R. (2003) A neurofilament antibody recognizes a subset of pyramidal cells in the human neocortex that are preserved in Alzheimer's disease. Neuropathology and Applied Neurobiology, 29 (3). pp. 316-320. ISSN 0305-1846

Condefer, K., Howarth, J. and Wilcock, G. (2003) Prediction rules for computed tomography in the dementia assessment: Do they predict clinical utility of CT? International Journal of Geriatric Psychiatry, 18 (4). pp. 285-287. ISSN 0885-6230

Hughes, A., Nicoll, J., Love, S. and Wilcock, G. (2003) APOE and cerebral amyloid angiopathy in the elderly. NeuroReport , 14. pp. 1535-1536.

Chalmers, K., Wilcock, G. and Love, S. (2003) APOEɛ4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of Aβ protein. Neuropathology and Applied Neurobiology, 29 (3). pp. 231-238. ISSN 0305-1846

Wozniak, M., Cookson, R., Itzhaki, R. and Wilcock, G. (2003) Absence of Chlamydia pneumoniae in brain of vascular dementia patients. Neurobiology of Aging, 24 (6). -.

Wilcock, G. (2003) Dementia with Lewy bodies. The Lancet. pp. 1689-1690.

Wilcock, G. (2003) Effect of vitamins and aspirin on markers of platelet activation oxidative stress and homocysteine in people at high risk of dementia. Journal of Medicine, 254 (1). pp. 67-75.

Tallon, D., Philip, J., Vedhara, K., Hunt, M., Shanks, N., Perks, P., Bennett, P., Murphy, P., Jones, R., Clark, S., Shaw, S., Lightman, S. and Wilcock, G. (2003) Enhancement of Antibody Responses to Influenza Vaccination in the Elderly Carers of Dementia Patients following a Cognitive-Behavioural Stress Management Intervention. Psychotherapy and Psychosomatics , 72 (5). pp. 245-252.

H, C., Howe, I., Truyen, L., Bullock, R., Lilienfield, S., Zhu, Y. and Wilcock, G. (2003) A Long-Term Comparison of Galantamine and Donepezil in the Treatment of Alzheimer s Disease. Drugs and Aging, 20 (10). pp. 777-789.

Wilcock, G. (2003) Memantine for the treatment of dementia. Lancet Neurology, 2 (8). pp. 503-505.

R, B., Haworth, J., Tian, J. and Wilcock, G. (2003) Neuropsychological prediction of conversion to dementia from questionable dementia statistically significant but not yet clinically useful. Journal of Neurology Neurosurgery and Psychiatry, 74. -.

Joffres, C., J, H., Rockwood, R., Bucks, R. and Wilcock, G. (2003) Patterns of Clinically Detectable Treatment Effects with Galantamine A Qualitative Analysis. Dementia and Geriatric Cognitive Disorders, 15. pp. 26-33.

Van Baelen, B., Sano, M. and Wilcock, G. (2003) The effects of galantamine treatment on caregiver time in Alzheimer s disease. International Journal of Geriatric Psychatry, 18 (10). pp. 942-950.

Kehoe, P. G., Katzov, H., Feuk, L., Bennett, A. M., Johansson, B., Wiman, Björn, De Faire, U., Cairns, N. J., Wilcock, G., Brookes, A. J., Blennow, K. and Prince, J. A. (2003) Haplotypes extending across ACE are associated with Alzheimer's disease. Human Molecular Genetics, 12 (8). pp. 859-867. ISSN 0964-6906

Wilcock, G. (2002) alpha- and beta-secretase: profound changes in Alzheimer's disease. Biochemical and Biophysical Research Communications, 299 (3). -.

Wilcock, G., Mobius, H. and Stoffler, A. (2002) A double-blind placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). International Clinical Psychopharmacology, 17 (6). pp. 297-305. ISSN 0268-1315

Joffres, C., Rockwood, K. and Wilcock, G. (2002) Improving clinical descriptions to understand the effects of dementia treatment consensus recommendations. International Journal of Geriatric Psychiatry, 17 (11). -.

Taylor, G., Vipond, I., Paul, I., Matthews, S., Wilcock, G. and Caul, E. (2002) Failure to correlate C. pneumoniae with late onset alzheimers disease. Neurology, 59 (1). pp. 142-143. ISSN 0028-3878

Robertson, A., Clarke, A., Mason, G., Dawbarn, G., Burston, J., Sessions, R., Naylor, R., Allen, S., Tyler, S. and Wilcock, G. (2002) A discrete domain of the human TrkB receptor defines the binding sites for brain-derived and neurotrophic factor and neurotrophin-4. Biochemical and Biophysical Research Communications, 291 (7). pp. 501-507. ISSN 0006-291X

Wozniak, M., Itzhaki, R., Lin, W. and Wilcock, G. (2002) Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiology of Disease, 9 (1). pp. 82-87. ISSN 0969-9961

Jordan, A., Hughes, A. O., MacGowan, S. H. and Wilcock, G. (2002) Predicting progression to dementia in a memory clinic. Brain Aging International Journal, 2 (1). pp. 42-47.

Whitehead, A., Birks, J., Grimley-Evans, J. and Wilcock, G. (2002) The effect of selegiline in the treatment of people with Alzheimer's disease a meta-analysis of published trials. International Journal of Geriatric Psychiatry, 17 (2). pp. 175-183. ISSN 0885-6230

Van Diepen, E., Lindesay, J., Marudkar, M. and Wilcock, G. (2002) The second Leicester survey of memory clinics in the British Isles. International Journal of Geriatric Psychiatry, 17 (1). pp. 41-47. ISSN 0885-6230

Tales, A., Lush, D., Haworth, J., Butler, S., Troscienko, T. and Wilcock, G. (2001) The pupillary light reflex in aging and Alzheimer's disease. Aging, 13 (6). pp. 473-478. ISSN 0002-0966

Greene, J., Neal, J., Radenahmad, N., Pearson, R. and Wilcock, G. (2001) Accumulation of calbindin in cortical pyramidal cells with ageing a putative protective mechanism which fails in Alzheimer's disease. Neuropathology and applied neurobiology, 27 (5). pp. 339-342. ISSN 0305-1846

Baddeley, A., Baddeley, H., Bucks, R. and Wilcock, G. (2001) Attentional control in Alzheimer's disease. Brain, 124 (8). pp. 1492-1508. ISSN 0006-8950

Robertson, A., Clarke, A., Dawbarn, D., Bennett, G., Mason, J., Banfield, M., Naylor, R., Allen, S., Brain, S., Tyler, S. and Wilcock, G. (2001) Identification and structure of the nerve growth factor binding site on TrkA. Biochemical and Biophysical Research Communications, 282 (1). pp. 131-141. ISSN 0006-291X

Robertson, A., Dawbarn, D., Allen, S., Tyler, S. and Wilcock, G. (2001) Recombinant human nerve growth factor for clinical trials: Protein expression purification stability and characterisation of binding to infusion pumps. Journal of Biochemical and Biophysical Methods, 47 (3). pp. 239-255. ISSN 0165-022X

Vedhara, K., Shanks, N., Lightman, S. L. and Wilcock, G. (2001) Correlates and predictors of self-reported psychological and physical morbidity in chronic caregiver stress. Journal of Health Psychology, 6 (1). pp. 101-119. ISSN 1359-1053

Hughes, A., Ahmed, A., Morris, C., Wilcock, G., Ford, J., Cairns, N., MacGowan, S. and Jones, R. (2001) N-acetyltransferase (NAT2) genotype and susceptibility to AD, PD and DLB. Alzheimer's Reports, 4. pp. 137-44.

Book Section

Wilcock, G. (2003) Brocklehurst's Textbook of Geriatric Medicine and Gerontology (Chapter 64). In: (2003) Brocklehurst's Textbook of Geriatric Medicine and Gerontology (Chapter 64). London: UNSPECIFIED. ISBN

This list was generated on Wed Nov 26 02:57:23 2014 GMT.
Copyright 2013 © UWE better together